임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

27건 표시

4상모집 예정· NSAID (Non-Steroidal Anti-Inflammatory Drug)
Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer
리드: 대웅제약
상세 →NCT07533266
4상모집 중· Obesity and Type 2 Diabetes
Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity
협력: 대웅제약
상세 →NCT06782139
4상모집 중· Aortic Valve Stenosis
ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement
협력: 대웅제약
상세 →NCT05672836
4상모집 중· Type 2 Diabetes
Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis
협력: 대웅제약
상세 →NCT06399835
4상완료· Hepatitis B, Chronic
Efficacy and Safety of Switching to Vemliver From Entecavir in Chronic Hepatitis B Patients Previously Treated With Entecavir
리드: 대웅제약
상세 →NCT06000657
4상모집 중· Coronary Artery Disease
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)
협력: 대웅제약, 한미약품, 유한양행
상세 →NCT05845489
4상완료· Chronic Liver Disease
Study to Evaluate the Efficacy and Safety of DWJ1464 in Patients with Chronic Liver Disease
리드: 대웅제약
상세 →NCT06272630
4상완료· Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia
Effect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With ACS Undergoing PCI
협력: 대웅제약
상세 →NCT05661552
4상상태 미확인· Alzheimer Disease
Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease
리드: 대웅제약
상세 →NCT05383183
4상완료· Gastritis
Clinical Trial to Compare Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis
리드: 대웅제약
상세 →NCT05072938
4상완료· Gastric Cancer
To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy
리드: 대웅제약
상세 →NCT05410535
4상완료· Hypertension
Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab
리드: 대웅제약
상세 →NCT04120753
4상완료· Hepatitis B, Chronic
Evaluate the Efficacy and Safety to Tenofovir Disoproxil in Chronic Hepatitis B Patients
리드: 대웅제약
상세 →NCT03485534
4상상태 미확인· Spasticity as Sequela of Stroke
Dose-response Relationship of Botullinum Toxin (DWP 450) for Finger Flexor Spasticity
협력: 대웅제약
상세 →NCT03517319
4상상태 미확인· Alzheimer Disease
A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients
리드: 대웅제약
상세 →NCT02648906
4상완료· Fatigue
Clinical Trial to Evaluate the Efficacy and Safety of 'URSA SOFT CAP. (UDCA-003)' in Fatigue Patients With Liver Dysfunction
리드: 대웅제약
상세 →NCT02415777
4상완료· Fatigue
A Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of 'Ursa Complex Soft Cap. (UDCA-004)' in Patients With Physical Fatigue.
리드: 대웅제약
상세 →NCT02418130
4상완료· Diabetes Mellitus, Type 2
The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones
협력: 대웅제약
상세 →NCT02180334
4상완료· Coronary Heart Disease
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)
협력: 종근당, 대웅제약, 한미약품
상세 →NCT02044250
4상완료· Moderate-severe Glabellar Lines
Evaluation Onset Time of DWP450-004 and Safety in Moderate-severe Glabellar Lines
리드: 대웅제약
상세 →NCT02568150
4상상태 미확인· Coronary Artery Disease
Effects of Combined Therapy With Statin Plus Fenofibrate on Coronary Atherosclerotic Plaque Compared With Statin Alone
협력: 대웅제약
상세 →NCT02232360
4상조기 종료· Schizophrenia
The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine
협력: 대웅제약
상세 →NCT01654640
4상완료· Hypertension
Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With Olmesartan
협력: 대웅제약
상세 →NCT01552954
4상상태 미확인· Irritable Bowel Syndrome
Comparison of the Efficacy and Safety of Tiropramide and Octylonium in the Treatment of Irritable Bowel Syndrome
리드: 대웅제약
상세 →NCT01629212
4상완료· Central Precocious Puberty
The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty
리드: 대웅제약
상세 →NCT01634321
4상상태 미확인· Patients Taking Low-dose Aspirin
The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients
리드: 대웅제약
상세 →NCT01397240
4상완료· Hypertension
Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM
협력: 대웅제약
상세 →NCT01713920

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.